Rhone-Poulenc Rorer/Novo Nordisk HRT alliance to launch U.S. Estrofem oral estradiol in 1997.
Executive Summary
RHONE-POULENC RORER/NOVO NORDISK EXPECT ESTROFEM U.S. LAUNCH IN 1997 as part of the companies' worldwide strategic alliance to promote hormone replacement therapies for perimenopausal and postmenopausal women. The alliance, announced May 9, will begin operations in Europe in the next few months.